Crohn's disease in adolescents.
The clinical features of Crohn's disease manifest during adolescence are varied as in adults. The potential complication of growth impairment and concomitant delay in pubertal development is unique to this population. Cytokines released from the inflamed bowel and chronic nutritional insufficiency are the major factors in the pathophysiology of growth inhibition. Hence reduction of intestinal inflammation and consistent provision of adequate nutrition are of paramount importance in management. Drug treatment mirrors that of adults; few specifically paediatric clinical trials have been conducted. Enteral nutrition is an important therapeutic alternative for young patients. There is evidence that it constitutes both a primary therapy of inflammation and a means of providing the calories needed for growth. In the setting of extensive disease, dependency on corticosteroids should be minimized through judicious administration of immunosuppressive drugs. For an adolescent with localized stenotic disease, optimal management includes a timely referral for intestinal resection as a means of providing an asymptomatic interval during which growth and pubertal development can normalize.
Griffiths
A M
AM
Division of Gastroenterology/Nutrition, Hospital for Sick Children, Toronto, Ontario, Canada.
D000293:Adolescent; D003424:Crohn Disease / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006130:Growth Disorders / Q000209:etiology / Q000503:physiopathology; D006801:Humans